Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: BioElectronics Corporation

Market Cap 12.35M 10.67M 9.83M 9.2M 17.25M 1.17B 17.51M 116M 45.26M 571M 46.36M 45.37M 1.98B P/E Ratio 2020
-26.5x
P/E Ratio 2021 -95.5x
Enterprise Value 25.69M 22.19M 20.45M 19.14M 35.87M 2.44B 36.43M 241M 94.15M 1.19B 96.43M 94.38M 4.12B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 day+16.67%
1 month-20.00%
6 months+33.33%
1 week 0
Extreme 0.0003
0
1 month 0
Extreme 0.0003
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Sales & Marketing - 01/09/2017
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
+16.67%0.00%+100.00%-33.33% 8.65M
-1.33%-0.73%+16.53%-10.78% 174B
-0.45%-2.61%-19.74%+30.31% 146B
-0.38%-2.28%-10.25%-25.35% 127B
-0.55%-3.38%-52.97%-8.31% 69.72B
-0.76%-0.99%+13.25%-2.62% 49.01B
+0.67%-0.60%-24.14%-34.78% 44.74B
+0.22%-4.13%+10.90%+8.65% 36.67B
-1.17%-2.69%+3.87%+35.04% 34.91B
+1.04%+0.79%-9.79%-16.21% 29.65B
Average +1.40%-3.14%+2.77%-5.74% 71.22B
Weighted average by Cap. -0.55%-1.98%-7.27%-2.67%

Financials

2020 2021
Net sales 830K 716K 660K 618K 1.16M 78.85M 1.18M 7.8M 3.04M 38.38M 3.11M 3.05M 133M 1.61M 1.39M 1.28M 1.2M 2.25M 153M 2.28M 15.13M 5.9M 74.46M 6.04M 5.91M 258M
Net income -1.16M -1M -923K -864K -1.62M -110M -1.64M -10.9M -4.25M -53.65M -4.35M -4.26M -186M -290K -250K -231K -216K -405K -27.55M -411K -2.72M -1.06M -13.41M -1.09M -1.06M -46.43M
Net Debt 13.07M 11.29M 10.4M 9.74M 18.24M 1.24B 18.53M 123M 47.88M 605M 49.04M 48M 2.09B 13.34M 11.52M 10.62M 9.94M 18.63M 1.27B 18.92M 125M 48.89M 617M 50.07M 49.01M 2.14B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
12/06/26 0.000350 $ +16.67% 4,679,322
11/06/26 0.000300 $ -14.29% 16,731,964
10/06/26 0.000350 $ 0.00% 13,668,086
09/06/26 0.000350 $ 0.00% 7,850,012
08/06/26 0.000350 $ -12.50% 4,053,000
  1. Stock Market
  2. Stocks
  3. BIEL Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!